You are here

For Journalists

Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.

Please contact:

Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019


Press Releases

Jorge Palop
January 14, 2020

Gladstone researchers, in collaboration with Genentech, a member of the Roche group, have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer’s disease and a rare genetic form of epilepsy known as Dravet syndrome.

December 12, 2019

Five new members have joined the Gladstone Foundation Board, increasing the breadth of expertise and bringing the size of the board to 19.

November 20, 2019

Gladstone researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.

November 19, 2019

For a person with Alzheimer’s disease, there’s no turning back the clock. By the time she begins to experience memory loss and other worrisome signs, cognitive decline has already set in. And decades of clinical trials have failed to produce treatments that could help her regain her memory.

October 31, 2019

Alzheimer’s disease is a progressive neurodegenerative disease that causes loss of memory. Despite decades of research into how the disease causes brain cells to die, there is no cure.

October 24, 2019

Gladstone Institutes and Xyphos Biosciences have shown that a cell-based immunotherapy, convertibleCAR®, can reduce the latent reservoir of virus in HIV-infected patients on anti-retroviral therapy

October 8, 2019

SAN FRANCISCO, CA—October 08, 2019—Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes, has fundamentally changed the way scientists think of neurological disorders.

July 31, 2019

Keller’s work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine

July 29, 2019

First sequence of the Komodo dragon genome reveals clues about its evolution

July 24, 2019

SAN FRANCISCO, CA—Each year, 9 months of dreams shared by millions of parents-to-be turn to despair and fright when learning their child is born with a birth defect; an often-devastating event affecting one out of 20 children born worldwide.